Logo image of CAVEN.OL

CAVENDISH HYDROGEN ASA (CAVEN.OL) Stock Fundamental Analysis

OSL:CAVEN - Euronext Oslo - NO0013219535 - Common Stock - Currency: NOK

6.34  +0.44 (+7.46%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CAVEN. CAVEN was compared to 54 industry peers in the Electrical Equipment industry. CAVEN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CAVEN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CAVEN has reported negative net income.
CAVEN had a negative operating cash flow in the past year.
CAVEN.OL Yearly Net Income VS EBIT VS OCF VS FCFCAVEN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

CAVEN has a Return On Assets of -23.77%. This is amonst the worse of the industry: CAVEN underperforms 85.19% of its industry peers.
CAVEN's Return On Equity of -30.99% is on the low side compared to the rest of the industry. CAVEN is outperformed by 77.78% of its industry peers.
Industry RankSector Rank
ROA -23.77%
ROE -30.99%
ROIC N/A
ROA(3y)-52.23%
ROA(5y)N/A
ROE(3y)-492.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CAVEN.OL Yearly ROA, ROE, ROICCAVEN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

CAVEN has a better Gross Margin (51.50%) than 68.52% of its industry peers.
In the last couple of years the Gross Margin of CAVEN has grown nicely.
CAVEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.14%
GM growth 5YN/A
CAVEN.OL Yearly Profit, Operating, Gross MarginsCAVEN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

CAVEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CAVEN has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for CAVEN has been reduced compared to a year ago.
CAVEN.OL Yearly Shares OutstandingCAVEN.OL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
CAVEN.OL Yearly Total Debt VS Total AssetsCAVEN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

CAVEN has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
CAVEN has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. CAVEN outperforms 94.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.75%
CAVEN.OL Yearly LT Debt VS Equity VS FCFCAVEN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 3.97 indicates that CAVEN has no problem at all paying its short term obligations.
The Current ratio of CAVEN (3.97) is better than 96.30% of its industry peers.
CAVEN has a Quick Ratio of 2.92. This indicates that CAVEN is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CAVEN (2.92) is better than 94.44% of its industry peers.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 2.92
CAVEN.OL Yearly Current Assets VS Current LiabilitesCAVEN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.38% over the past year.
The Revenue has been growing slightly by 7.31% in the past year.
The Revenue has been decreasing by -0.24% on average over the past years.
EPS 1Y (TTM)21.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.1%
Revenue 1Y (TTM)7.31%
Revenue growth 3Y-0.24%
Revenue growth 5YN/A
Sales Q2Q%-77.84%

3.2 Future

The Earnings Per Share is expected to grow by 24.53% on average over the next years. This is a very strong growth
Based on estimates for the next years, CAVEN will show a very strong growth in Revenue. The Revenue will grow by 41.42% on average per year.
EPS Next Y1.45%
EPS Next 2Y24.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.93%
Revenue Next 2Y41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CAVEN.OL Yearly Revenue VS EstimatesCAVEN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
CAVEN.OL Yearly EPS VS EstimatesCAVEN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CAVEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CAVEN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CAVEN.OL Price Earnings VS Forward Price EarningsCAVEN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAVEN.OL Per share dataCAVEN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as CAVEN's earnings are expected to grow with 24.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.53%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CAVEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAVENDISH HYDROGEN ASA

OSL:CAVEN (4/28/2025, 1:33:43 PM)

6.34

+0.44 (+7.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-28 2024-11-28/bmo
Earnings (Next)N/A N/A
Inst Owners8.63%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap213.15M
Analysts86.67
Price Target18.02 (184.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.58%
Min Revenue beat(2)-30.83%
Max Revenue beat(2)-22.33%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)88.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.3
EV/EBITDA N/A
EPS(TTM)-7.98
EYN/A
EPS(NY)-8.29
Fwd EYN/A
FCF(TTM)-11.2
FCFYN/A
OCF(TTM)-8.49
OCFYN/A
SpS10.92
BVpS25.75
TBVpS21.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.77%
ROE -30.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.5%
FCFM N/A
ROA(3y)-52.23%
ROA(5y)N/A
ROE(3y)-492.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.14%
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 167.39%
Cap/Sales 24.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.97
Quick Ratio 2.92
Altman-Z N/A
F-Score3
WACC6.75%
ROIC/WACCN/A
Cap/Depr(3y)90.31%
Cap/Depr(5y)N/A
Cap/Sales(3y)21.12%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.1%
EPS Next Y1.45%
EPS Next 2Y24.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.31%
Revenue growth 3Y-0.24%
Revenue growth 5YN/A
Sales Q2Q%-77.84%
Revenue Next Year25.93%
Revenue Next 2Y41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-448.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.15%
OCF growth 3YN/A
OCF growth 5YN/A